| Event |
30 days |
180 days |
360 days |
| Death |
0.0% (0/50) |
2.5% (1/40) |
3.1% (1/32) |
| Q-Wave MI |
0.0% (0/50) |
0.0% (0/40) |
0.0 % (0/32) |
| Non Q-Wave MI |
0.0% (0/50) |
2.5% (1/40) |
6.3% (2/32) |
| Target Lesion CABG |
0.0% (0/50) |
0.0% (0/40) |
0.0% (0/32) |
| Target Vessel CABG |
0.0% (0/50) |
2.5% (1/40) |
9.4% (3/32) |
| Target Lesion Revascularization |
0.0% (0/50) |
7.5% (3/40) |
15.6% (5/32) |
| Target Vessel Revascularization |
2.0% (1/50) |
10.00% (4/40) |
18.8% (6/32) |
| Acute Stent Thrombosis |
0.0% (0/50) |
0.0% (0/40) |
0.0% (0/32) |
| Subacute Stent Thrombosis |
0.0% (0/50) |
0.0% (0/40) |
0.0% (0/32) |
| Late Stent Thrombosis |
0.0% (0/50) |
2.5% (1/40) |
3.1% (1/32) |
| MACE
(Death, MI, CABG, TLR) |
0.0% (0/50) |
10.00% (4/40) |
21.9% (7/32) |
|
